Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...
A new drug has shown major promise on its ability to suppress advanced lung cancer into a manageable chronic disease, ...
SurvivorNet on MSN
New lung cancer drug, Ivonescimab, showed promising results in major HARMONi-6 trial, but US patients will need to wait for HARMONi-3 update
A new drug called ivonescimab just beat standard immunotherapy in a major lung cancer trial: patients lived nearly four ...
Experts have described the findings as a ‘promising step forward‘ for patients with advanced squamous non-small cell lung ...
About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in ...
Results from a study on an investigational combination treatment for patients with advanced KRAS G12C+ non-small cell lung ...
Lung cancer remains one of the world's deadliest cancers, yet despite decades of effort to develop new drugs, many fail because they don't stay in the body long enough to be effective or because they ...
The FDA approved Keytruda for NSCLC based on several clinical trials. Keytruda was studied in people whose NSCLC had spread to other parts of the body (metastatic) and who had received no prior ...
A former Ironman triathlete was stunned to learn that his vision problems were actually the first sign of stage 4 lung cancer. Dave Nitsche, 57, was initially given just 12 to 24 months to live – but ...
Treatment for lung cancer has changed significantly with immunotherapy, an expert said during the CURE® Educated Patient® Lung Cancer Summit. For patients with advanced-stage non-small cell lung ...
Research findings are mixed, but several studies link both short and long sleep duration with a higher risk of lung cancer than a moderate amount of sleep. Lung cancer and its treatment can disrupt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results